Your browser doesn't support javascript.
loading
Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.
Hosomi, Koji; Saito, Mayu; Park, Jonguk; Murakami, Haruka; Shibata, Naoko; Ando, Masahiro; Nagatake, Takahiro; Konishi, Kana; Ohno, Harumi; Tanisawa, Kumpei; Mohsen, Attayeb; Chen, Yi-An; Kawashima, Hitoshi; Natsume-Kitatani, Yayoi; Oka, Yoshimasa; Shimizu, Hidenori; Furuta, Mari; Tojima, Yoko; Sawane, Kento; Saika, Azusa; Kondo, Saki; Yonejima, Yasunori; Takeyama, Haruko; Matsutani, Akira; Mizuguchi, Kenji; Miyachi, Motohiko; Kunisawa, Jun.
Afiliación
  • Hosomi K; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Saito M; Laboratory of Gut Environmental System, Collaborative Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Park J; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Murakami H; Noster Inc., 35-3 Minamibiraki, Kamiueno-cho, Muko, Kyoto, 617-0006, Japan.
  • Shibata N; Laboratory of In-silico Drug Design, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Ando M; Department of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 1-23-1 Toyama, Shinjuku, Tokyo, 162-8636, Japan.
  • Nagatake T; Faculty of Sport and Health Science, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, 525-0085, Japan.
  • Konishi K; Research Organization for Nano and Life Innovation, Waseda University, 513 Waseda-Tsurumaki-cho, Shinjuku, Tokyo, 162-0041, Japan.
  • Ohno H; Research Organization for Nano and Life Innovation, Waseda University, 513 Waseda-Tsurumaki-cho, Shinjuku, Tokyo, 162-0041, Japan.
  • Tanisawa K; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Mohsen A; Department of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 1-23-1 Toyama, Shinjuku, Tokyo, 162-8636, Japan.
  • Chen YA; Faculty of Food and Nutritional Sciences, Toyo University, 1-1-1 Izumino, Itakura, Oura, Gunma, 374-0193, Japan.
  • Kawashima H; Department of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 1-23-1 Toyama, Shinjuku, Tokyo, 162-8636, Japan.
  • Natsume-Kitatani Y; Department of Nutrition, Kiryu University, 606-7 Azami, Kasakake-machi, Midori, Gunnma, 379-2392, Japan.
  • Oka Y; Department of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 1-23-1 Toyama, Shinjuku, Tokyo, 162-8636, Japan.
  • Shimizu H; Faculty of Sport Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa, Saitama, 359-1192, Japan.
  • Furuta M; Laboratory of In-silico Drug Design, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Tojima Y; Laboratory of In-silico Drug Design, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Sawane K; Laboratory of In-silico Drug Design, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Saika A; Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Kondo S; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Yonejima Y; Noster Inc., 35-3 Minamibiraki, Kamiueno-cho, Muko, Kyoto, 617-0006, Japan.
  • Takeyama H; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Matsutani A; Noster Inc., 35-3 Minamibiraki, Kamiueno-cho, Muko, Kyoto, 617-0006, Japan.
  • Mizuguchi K; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Miyachi M; Laboratory of Gut Environmental System, Collaborative Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
  • Kunisawa J; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.
Nat Commun ; 13(1): 4477, 2022 08 18.
Article en En | MEDLINE | ID: mdl-35982037
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metabolismo de los Hidratos de Carbono / Clostridiales / Microbioma Gastrointestinal / Obesidad Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metabolismo de los Hidratos de Carbono / Clostridiales / Microbioma Gastrointestinal / Obesidad Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Japón